ConductScience.org, home

Comparison · NCT04536038-da67a7b8

Opt-in vs Opt-out: Enrollment in GAMEPAD Intervention Study

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Opt-in vs Opt-out: Enrollment in GAMEPAD Intervention Study. Trial comparisons, record NCT04536038-da67a7b8. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04536038-da67a7b8

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.009980.007310.0136wilson
Risk in group 20.03550.02660.0472wilson
Risk difference, group 1 minus group 2-0.0255-0.0375-0.016newcombe hybrid score
Risk ratio, group 1 over group 20.2810.1840.429log
Odds ratio, group 1 over group 20.2740.1770.422log
Number needed to treat, for one fewer participant with the outcome on Opt-in than on Opt-out39.226.762.7from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Opt-in
Patients randomized to opt-in framing will be instructed to visit the Way to Health website to enroll in the study, or to call or email the study coordinator with questions or for assistance in enrolling.
393,909OG000
Group 2Opt-out
Patients randomized to opt-out framing will receive an email that frames participation in the study as part of the standard of care, and will be informed that a study coordinator will be calling them in the coming days to start enrollment in the study unless they opt out of participation.~Opt-out: A study coordinator will call the patient unless they opt-out. See arm description for more details.
451,267OG001

Outcome

Type
PRIMARY
Title
Enrollment in GAMEPAD Intervention Study
Description
The proportion of patients that enroll in the GAMEPAD intervention study
Time frame
Enrollment (period of approximately 6 months)
Population
The number of participants reported in the Participant Flow are participants that were active in the GAMEPAD trial. Participants Analyzed above are all the participants randomized to either opt in or opt out recruitment style that was contacted to be a part of the GAMEPAD Study.

Source ClinicalTrials.gov

Trial

Title
Framing Clinical Trial Enrollment for Patients With Peripheral Artery Disease
NCT number
NCT04536038
Phases
NA
Conditions
Peripheral Artery Disease
Interventions
Opt-out
Lead sponsor
University of Pennsylvania
Results first posted
2025-12-24

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04536038-da67a7b8